Arthritis Research & Therapy has launched a new thematic series dedicated to the topic Digital Rheumatology.
Thematic series on Digital Rheumatology
Articles
-
-
The risk of newly diagnosed cancer in patients with rheumatoid arthritis by TNF inhibitor use: a nationwide cohort study
-
Treatment of rheumatoid arthritis and its outcomes in an aging society: a single-center cohort study in Japan from 2011 to 2020
-
Identification of TMEM129, encoding a ubiquitin-protein ligase, as an effector gene of osteoarthritis genetic risk
-
A randomized, double-blind, placebo-controlled 12-week trial of infliximab in patients with juvenile-onset spondyloarthritis
-
Use of NSAIDs in treating patients with arthritis
-
Repression of anti-proliferative factor Tob1in osteoarthritic cartilage
-
A concise history of gout and hyperuricemia and their treatment
-
Subchondral bone in osteoarthritis: insight into risk factors and microstructural changes
-
Degeneration of the intervertebral disc
Join our 20th anniversary celebrations by browsing through the journal’s milestone achievements and our specially commissioned Editorial collection.
Editors-in-Chief
Professor Christopher Buckley, University of Birmingham and University of Oxford, UK
Professor Harris Perlman, Northwestern University, USA
Trending articles
Click here to view which articles have been shared the most in the last month.
First Author Profiles
Meet this month's featured authors!
Aims and scope
Established in 1999, Arthritis Research and Therapy is an international, open access, peer-reviewed journal, publishing original articles in the area of musculoskeletal research and therapy as well as, reviews, commentaries and reports.
A major focus of the journal is on the immunologic processes leading to inflammation, damage and repair as they relate to autoimmune rheumatic and musculoskeletal conditions, and which inform the translation of this knowledge into advances in clinical care.
Original basic, translational and clinical research is considered for publication along with results of early and late phase therapeutic trials, especially as they pertain to the underpinning science that informs clinical observations in interventional studies.
A major focus of the journal is on the immunologic processes leading to inflammation, damage and repair as they relate to autoimmune rheumatic and musculoskeletal conditions, and which inform the translation of this knowledge into advances in clinical care.
Original basic, translational and clinical research is considered for publication along with results of early and late phase therapeutic trials, especially as they pertain to the underpinning science that informs clinical observations in interventional studies.
Featured Review: The importance of ultrasound in identifying and differentiating patients with early inflammatory arthritis
Kaeley et al. provide an in-depth review of how ultrasound—a portable, convenient, noninvasive, and cost-effective imaging technique—can be used in the differential diagnosis of early inflammatory arthritis phenotypes and also assess any important limitations of the technique. The authors also propose an algorithm that may enable working through a differential diagnosis both clinically and by prioritizing anatomical targets.
Follow
Annual Journal Metrics
-
Citation Impact
5.606 - 2-year Impact Factor (2021)
5.987 - 5-year Impact Factor (2021)
1.512 - Source Normalized Impact per Paper (SNIP)
1.788 - SCImago Journal Rank (SJR)Speed
41 days to first decision for all manuscripts (Median)
130 days to first decision for reviewed manuscripts only (Median)Usage
3,062,444 Downloads (2021)
11979 Altmetric mentions (2021)